The FDA has no idea what's going on in the trial until the data's sent. You're correct, the DSMB is the only entity that does, and they said what they said and didn't do what one would expect; make sure the trial wasn't going off into the weeds.

Who comprised the DSMB, anyone know?

Quote:

---

But what about the role of the DSMB? Isn't their function to review and advise CytoDyn through the trial process? They raised no flags over these shortcomings as far as we know. According to reports from our CEO, all they had to offer was "keep on doing what you're doing."


Read More: https://investorshangout.com/post/view?id=607...z6oiqVgig8

---